Effects of salicylate-copper complex on the metabolic activation in phagocytizing granulocytes.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001711:Biotransformation / Q000187:drug effects*; D003300:Copper / Q000494:pharmacology*; D006098:Granulocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D009942:Organometallic Compounds; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects*; D012459:Salicylates / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D009942:Organometallic Compounds; D012459:Salicylates; C025564:copper salicylate complex; D003300:Copper